Correlation Between AcelRx Pharmaceuticals and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both AcelRx Pharmaceuticals and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AcelRx Pharmaceuticals and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AcelRx Pharmaceuticals and Sunshine Biopharma, you can compare the effects of market volatilities on AcelRx Pharmaceuticals and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AcelRx Pharmaceuticals with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AcelRx Pharmaceuticals and Sunshine Biopharma.
Diversification Opportunities for AcelRx Pharmaceuticals and Sunshine Biopharma
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AcelRx and Sunshine is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding AcelRx Pharmaceuticals and Sunshine Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and AcelRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AcelRx Pharmaceuticals are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of AcelRx Pharmaceuticals i.e., AcelRx Pharmaceuticals and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between AcelRx Pharmaceuticals and Sunshine Biopharma
If you would invest 282.00 in Sunshine Biopharma on September 1, 2024 and sell it today you would earn a total of 4.00 from holding Sunshine Biopharma or generate 1.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
AcelRx Pharmaceuticals vs. Sunshine Biopharma
Performance |
Timeline |
AcelRx Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Sunshine Biopharma |
AcelRx Pharmaceuticals and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AcelRx Pharmaceuticals and Sunshine Biopharma
The main advantage of trading using opposite AcelRx Pharmaceuticals and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AcelRx Pharmaceuticals position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.AcelRx Pharmaceuticals vs. Lifecore Biomedical | AcelRx Pharmaceuticals vs. Shuttle Pharmaceuticals | AcelRx Pharmaceuticals vs. Catalent | AcelRx Pharmaceuticals vs. Tilray Inc |
Sunshine Biopharma vs. Tff Pharmaceuticals | Sunshine Biopharma vs. Eliem Therapeutics | Sunshine Biopharma vs. Inhibrx | Sunshine Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |